Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra IL-1 inhibition in acute gout
2014-000173-39Phase 4Completed
- Sponsor
- Jan van Breemen Research Institute Reade
- Start
- Jul 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of anakinra in gout, sponsored by Jan van Breemen Research Institute Reade. Primary endpoint: Pain reduction at 72 hours. Started Jul 2014; status: completed.
02
Drugs
anakinra
03
Conditions
gout
Beyond the preview
Go deeper on 2014-000173-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000173-39.